Literature DB >> 28255189

Personalized Dose Finding Using Outcome Weighted Learning.

Guanhua Chen1, Donglin Zeng2, Michael R Kosorok3.   

Abstract

In dose-finding clinical trials, it is becoming increasingly important to account for individual level heterogeneity while searching for optimal doses to ensure an optimal individualized dose rule (IDR) maximizes the expected beneficial clinical outcome for each individual. In this paper, we advocate a randomized trial design where candidate dose levels assigned to study subjects are randomly chosen from a continuous distribution within a safe range. To estimate the optimal IDR using such data, we propose an outcome weighted learning method based on a nonconvex loss function, which can be solved efficiently using a difference of convex functions algorithm. The consistency and convergence rate for the estimated IDR are derived, and its small-sample performance is evaluated via simulation studies. We demonstrate that the proposed method outperforms competing approaches. Finally, we illustrate this method using data from a cohort study for Warfarin (an anti-thrombotic drug) dosing.

Entities:  

Keywords:  DC Algorithm; Dose Finding; Individualized Dose Rule; Risk Bound; Weighted Support Vector Regression

Year:  2017        PMID: 28255189      PMCID: PMC5327863          DOI: 10.1080/01621459.2016.1148611

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  20 in total

1.  Predicting warfarin dosage from clinical data: a supervised learning approach.

Authors:  Ya-Han Hu; Fan Wu; Chia-Lun Lo; Chun-Tien Tai
Journal:  Artif Intell Med       Date:  2012-04-24       Impact factor: 5.326

2.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

3.  Calibrating parametric subject-specific risk estimation.

Authors:  T Cai; L Tian; Hajime Uno; Scott D Solomon; L J Wei
Journal:  Biometrika       Date:  2010-06       Impact factor: 2.445

4.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

5.  A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.

Authors:  P F Thall; K E Russell
Journal:  Biometrics       Date:  1998-03       Impact factor: 2.571

6.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

Review 7.  Systematic overview of warfarin and its drug and food interactions.

Authors:  Anne M Holbrook; Jennifer A Pereira; Renee Labiris; Heather McDonald; James D Douketis; Mark Crowther; Philip S Wells
Journal:  Arch Intern Med       Date:  2005-05-23

8.  Q-learning for estimating optimal dynamic treatment rules from observational data.

Authors:  Erica E M Moodie; Bibhas Chakraborty; Michael S Kramer
Journal:  Can J Stat       Date:  2012-11-07       Impact factor: 0.875

9.  Estimating Optimal Treatment Regimes from a Classification Perspective.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Marie Davidian; Min Zhang; Eric Laber
Journal:  Stat       Date:  2012-01-01

10.  Estimation of the warfarin dose with clinical and pharmacogenetic data.

Authors:  T E Klein; R B Altman; N Eriksson; B F Gage; S E Kimmel; M-T M Lee; N A Limdi; D Page; D M Roden; M J Wagner; M D Caldwell; J A Johnson
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245

View more
  13 in total

1.  Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times.

Authors:  Juhee Lee; Peter F Thall; Katy Rezvani
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2018-03-15       Impact factor: 1.864

2.  Estimating individualized treatment rules for ordinal treatments.

Authors:  Jingxiang Chen; Haoda Fu; Xuanyao He; Michael R Kosorok; Yufeng Liu
Journal:  Biometrics       Date:  2018-03-13       Impact factor: 2.571

3.  Precision Medicine.

Authors:  Michael R Kosorok; Eric B Laber
Journal:  Annu Rev Stat Appl       Date:  2019-03       Impact factor: 5.810

4.  Prospects and challenges for clinical decision support in the era of big data.

Authors:  Issam El Naqa; Michael R Kosorok; Judy Jin; Michelle Mierzwa; Randall K Ten Haken
Journal:  JCO Clin Cancer Inform       Date:  2018-11-09

5.  A single-index model with a surface-link for optimizing individualized dose rules.

Authors:  Hyung Park; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  J Comput Graph Stat       Date:  2021-06-21       Impact factor: 1.884

6.  Estimation and Optimization of Composite Outcomes.

Authors:  Daniel J Luckett; Eric B Laber; Siyeon Kim; Michael R Kosorok
Journal:  J Mach Learn Res       Date:  2021-01       Impact factor: 5.177

7.  Constructing dynamic treatment regimes with shared parameters for censored data.

Authors:  Ying-Qi Zhao; Ruoqing Zhu; Guanhua Chen; Yingye Zheng
Journal:  Stat Med       Date:  2020-01-17       Impact factor: 2.373

8.  A semiparametric instrumental variable approach to optimal treatment regimes under endogeneity.

Authors:  Yifan Cui; Eric Tchetgen Tchetgen
Journal:  J Am Stat Assoc       Date:  2020-08-04       Impact factor: 5.033

9.  A utility approach to individualized optimal dose selection using biomarkers.

Authors:  Pin Li; Jeremy M G Taylor; Spring Kong; Shruti Jolly; Matthew J Schipper
Journal:  Biom J       Date:  2019-11-06       Impact factor: 1.715

10.  A spatiotemporal recommendation engine for malaria control.

Authors:  Qian Guan; Brian J Reich; Eric B Laber
Journal:  Biostatistics       Date:  2022-07-18       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.